-->
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Global Market: CAGR Calculation
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Equine Healthcare Market Variable Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Include Growing R&D Initiatives,
3.2.1.2. Rise In Equine Health Complications,
3.2.1.3. Rising Popularity Of Equine-Assisted Therapy
3.2.1.4. Emergence Of Artificial Intelligence (AI) In Equine Health
3.2.2. Market Restraint Analysis
3.2.2.1. High Cost of Expenditure
3.2.2.2. Availability of Substitutes
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Equine Healthcare Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.3. Regulatory Framework
3.3.4. Estimated Horse Population, by Key Countries, 2018 - 2023
3.3.5. Pricing Analysis
3.3.6. COVID-19 Impact Analysis
Chapter 4. Equine Healthcare Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Equine Healthcare Market Product Movement Analysis
4.3. Equine Healthcare Market Size & Trend Analysis, By Product, 2024-2032
4.3.1. Vaccines
4.3.1.1. Market estimates and forecasts 2024-2032
4.3.2. Pharmaceuticals
4.3.2.1. Market estimates and forecasts 2024-2032
4.3.2.2. Parasiticides
4.3.2.2.1. Market estimates and forecasts 2024-2032
4.3.2.3. Anti-infectives
4.3.2.3.1. Market estimates and forecasts 2024-2032
4.3.2.4. Anti-inflammatory & Analgesics
4.3.2.4.1. Market estimates and forecasts 2024-2032
4.3.2.5. Other Pharmaceuticals
4.3.2.5.1. Market estimates and forecasts 2024-2032
4.3.3. Medicinal Feed Additives
4.3.3.1. Market estimates and forecasts 2024-2032
4.3.4. Orthobiologics
4.3.4.1. Market estimates and forecasts 2024-2032
4.3.5. Diagnostics
4.3.5.1. Market estimates and forecasts 2024-2032
4.3.5.2. Diagnostic Test Kits
4.3.5.2.1. Market estimates and forecasts 2024-2032
4.3.5.3. Diagnostic Equipment
4.3.5.3.1. Market estimates and forecasts 2024-2032
4.3.6. Software & Services
4.3.6.1. Market estimates and forecasts 2024-2032
4.3.6.2. Practice Management Software
4.3.6.2.1. Market estimates and forecasts 2024-2032
4.3.6.3. Imaging Software
4.3.6.3.1. Market estimates and forecasts 2024-2032
4.3.6.4. Telehealth Software
4.3.6.4.1. Market estimates and forecasts 2024-2032
4.3.6.5. Other Software
4.3.6.5.1. Market estimates and forecasts 2024-2032
4.3.7. Other Products
4.3.7.1. Market estimates and forecasts 2024-2032
Chapter 5. Equine Healthcare Market: Indication Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Equine Healthcare Market Movement Analysis
5.3. Equine Healthcare Market Size & Trend Analysis, Indication, 2024-2032
5.3.1. Musculoskeletal Disorders
5.3.1.1. Market estimates and forecasts 2024-2032
5.3.2. Parasitic Infections
5.3.2.1. Market estimates and forecasts 2024-2032
5.3.3. Equine Herpes Virus
5.3.3.1. Market estimates and forecasts 2024-2032
5.3.4. Equine Viral Arteritis (EVA)
5.3.4.1. Market estimates and forecasts 2024-2032
5.3.5. Equine Influenza
5.3.5.1. Market estimates and forecasts 2024-2032
5.3.6. West Nile Virus
5.3.6.1. Market estimates and forecasts 2024-2032
5.3.7. Tetanus
5.3.7.1. Market estimates and forecasts 2024-2032
5.3.8. Other Indications
5.3.8.1. Market estimates and forecasts 2024-2032
Chapter 6. Equine Healthcare Market: By Activity Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Equine Healthcare Market Movement Analysis
6.3. Equine Healthcare Market Size & Trend Analysis, Activity type, 2024-2032
6.3.1. Sports/Racing
6.3.1.1. Market estimates and forecasts 2024-2032
6.3.2. Recreation
6.3.2.1. Market estimates and forecasts 2024-2032
6.3.3. Other Activities
6.3.3.1. Market estimates and forecasts 2024-2032
Chapter 7. Equine Healthcare Market: By Distribution Channel Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Equine Healthcare Market Movement Analysis
7.3. Equine Healthcare Market Size & Trend Analysis, By Distribution Channel, 2024-2032
7.3.1. Veterinary Hospitals & Clinics
7.3.1.1. Market estimates and forecasts 2024-2032
7.3.2. E-commerce
7.3.2.1. Market estimates and forecasts 2024-2032
7.3.3. Equestrian Facilities
7.3.3.1. Market estimates and forecasts 2024-2032
7.3.4. Other Channels
7.3.4.1. Market estimates and forecasts 2024-2032
Chapter 8. Equine Healthcare Market: Country Estimates & Trend Analysis, by Product, Indication, Activity & Distribution Channel
8.1. Regional Dashboard
8.2. Equine Healthcare Market Share, By Region, 2023 & 2030, USD Million
8.3. Regional Outlook
8.4. North America
8.4.1. North America Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.2. U.S.
8.4.2.1. Key Country Dynamics
8.4.2.2. Competition Insights
8.4.2.3. U.S. Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.3. Canada
8.4.3.1. Key Country Dynamics
8.4.3.2. Competition Insights
8.4.3.3. Canada Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.4. Mexico
8.4.4.1. Key Country Dynamics
8.4.4.2. Competition Insights
8.4.4.3. Mexico Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5. Europe
8.5.1. Europe Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.2. UK
8.5.2.1. Key Country Dynamics
8.5.2.2. Competition Insights
8.5.2.3. UK Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.3. Germany
8.5.3.1. Key Country Dynamics
8.5.3.2. Competition Insights
8.5.3.3. Germany Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.4. France
8.5.4.1. Key Country Dynamics
8.5.4.2. Competition Insights
8.5.4.3. France Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.5. Italy
8.5.5.1. Key Country Dynamics
8.5.5.2. Competition Insights
8.5.5.3. Italy Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.6. Spain
8.5.6.1. Key Country Dynamics
8.5.6.2. Competition Insights
8.5.6.3. Spain Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.7. Denmark
8.5.7.1. Key Country Dynamics
8.5.7.2. Competition Insights
8.5.7.3. Denmark Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.8. Sweden
8.5.8.1. Key Country Dynamics
8.5.8.2. Competition Insights
8.5.8.3. Sweden Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.9. Norway
8.5.9.1. Key Country Dynamics
8.5.9.2. Competition Insights
8.5.9.3. Norway Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.10. Netherlands
8.5.10.1. Key Country Dynamics
8.5.10.2. Competition Insights
8.5.10.3. Netherlands Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.11. Russia
8.5.11.1. Key Country Dynamics
8.5.11.2. Competition Insights
8.5.11.3. Russia Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.12. Switzerland
8.5.12.1. Key Country Dynamics
8.5.12.2. Competition Insights
8.5.12.3. Switzerland Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.2. Japan
8.6.2.1. Key Country Dynamics
8.6.2.2. Competition Insights
8.6.2.3. Japan Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.3. China
8.6.3.1. Key Country Dynamics
8.6.3.2. Competition Insights
8.6.3.3. China Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.4. India
8.6.4.1. Key Country Dynamics
8.6.4.2. Competition Insights
8.6.4.3. India Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.5. Australia
8.6.5.1. Key Country Dynamics
8.6.5.2. Competition Insights
8.6.5.3. Australia Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.6. South Korea
8.6.6.1. Key Country Dynamics
8.6.6.2. Competition Insights
8.6.6.3. South Korea Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.7. Thailand
8.6.7.1. Key Country Dynamics
8.6.7.2. Competition Insights
8.6.7.3. Thailand Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7. Latin America
8.7.1. Latin America Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Competition Insights
8.7.2.3. Brazil Equine Healthcare Market Estimates And Forecasts, 2018 - 2030
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Competition Insights
8.7.3.3. Argentina Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8. Middle East & Africa
8.8.1. Middle East & Africa Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. Competition Insights
8.8.2.3. South Africa Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Competition Insights
8.8.3.3. Saudi Arabia Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. Competition Insights
8.8.4.3. UAE Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key Country Dynamics
8.8.5.2. Competition Insights
8.8.5.3. Kuwait Equine Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.2. Participants Overview
9.3. Financial Performance
9.4. Product Benchmarking
9.5. Market Position Analysis, 2023 (Heat Map Analysis)
9.6. Strategy Mapping
9.6.1. Mergers And Acquisitions
9.6.2. Launch
9.6.3. Partnerships & Collaborations
9.6.4. Expansion
9.6.5. Others
9.7. Company Profiles
9.7.1. Zoetis
9.7.1.1. Participant’s overview
9.7.1.2. Financial performance
9.7.1.3. Product benchmarking
9.7.1.4. Strategic initiatives
9.7.2. Arthrex Inc.
9.7.2.1. Participant’s overview
9.7.2.2. Financial performance
9.7.2.3. Product benchmarking
9.7.2.4. Strategic initiatives
9.7.3. Dechra Pharmaceuticals
9.7.3.1. Participant’s overview
9.7.3.2. Financial performance
9.7.3.3. Product benchmarking
9.7.3.4. Strategic initiatives
9.7.4. Boehringer Ingelheim
9.7.4.1. Participant’s overview
9.7.4.2. Financial performance
9.7.4.3. Product benchmarking
9.7.4.4. Strategic initiatives
9.7.5. Ceva Sante Animale
9.7.5.1. Participant’s overview
9.7.5.2. Financial performance
9.7.5.3. Product benchmarking
9.7.5.4. Strategic initiatives
9.7.6. Heska Corporation
9.7.6.1. Participant’s overview
9.7.6.2. Financial performance
9.7.6.3. Product benchmarking
9.7.6.4. Strategic initiatives
9.7.7. Merck & Co Inc.
9.7.7.1. Participant’s overview
9.7.7.2. Financial performance
9.7.7.3. Product benchmarking
9.7.7.4. Strategic initiatives
9.7.8. Esaote SpA
9.7.8.1. Participant’s overview
9.7.8.2. Financial performance
9.7.8.3. Product benchmarking
9.7.8.4. Strategic initiatives
9.7.9. IDEXX Laboratories Inc.
9.7.9.1. Participant’s overview
9.7.9.2. Financial performance
9.7.9.3. Product benchmarking
9.7.9.4. Strategic initiatives
9.7.10. Covetrus Inc.
9.7.10.1. Participant’s overview
9.7.10.2. Financial performance
9.7.10.3. Product benchmarking
9.7.10.4. Strategic initiatives
9.7.11. Elanco
9.7.11.1. Participant’s overview
9.7.11.2. Financial performance
9.7.11.3. Product benchmarking
9.7.11.4. Strategic initiatives
9.7.12. Cargill
9.7.12.1. Participant’s overview
9.7.12.2. Financial performance
9.7.12.3. Product benchmarking
9.7.12.4. Strategic initiatives
9.8. List of Other Key Market Players
著作権 ©2022 無断複写・転載を禁じます